L
Luis M. Montuenga
Researcher at University of Navarra
Publications - 245
Citations - 10844
Luis M. Montuenga is an academic researcher from University of Navarra. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 48, co-authored 221 publications receiving 9205 citations. Previous affiliations of Luis M. Montuenga include Chartered Institute of Management Accountants & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
TRAP1 Regulates Proliferation, Mitochondrial Function and has Prognostic Significance in NSCLC
Jackeline Agorreta,Jianting Hu,Dongxia Liu,Domenico Delia,Helen Turley,David J P Ferguson,Francisco J. Iborra,Maria J. Pajares,Marta Larrayoz,Isabel Zudaire,Ruben Pio,Luis M. Montuenga,Adrian L. Harris,Kevin C. Gatter,Francesco Pezzella +14 more
TL;DR: It is demonstrated that TRAP1 impacts the viability of NSCLC cells, and that its expression is prognostic inNSCLC.
Journal ArticleDOI
Alternative splicing in lung cancer.
Ruben Pio,Luis M. Montuenga +1 more
TL;DR: The evidence supporting the relevance of alternative splicing in lung cancer is summarized and the potential significance ofAlternative splicing as a target for lung cancer diagnosis or treatment will be discussed.
Journal ArticleDOI
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
Fernando J. de Miguel,Fernando J. de Miguel,Maria J. Pajares,Maria J. Pajares,Elena Martínez-Terroba,Elena Martínez-Terroba,Daniel Ajona,Daniel Ajona,Xabier Morales,Ravi Datta Sharma,F. Pardo,Ana Rouzaut,Ana Rouzaut,Angel Rubio,Luis M. Montuenga,Luis M. Montuenga,Ruben Pio,Ruben Pio +17 more
TL;DR: It is shown that low nuclear QKI expression in non‐small cell lung cancer is an independent prognostic factor for disease‐free survival (HR = 2.47; 95% CI = 1.11–5.46), and ESYT2, one of the QKI targets, is involved in cytoskeletal organization.
Journal ArticleDOI
Adrenomedullin functions as an important tumor survival factor in human carcinogenesis.
Frank Cuttitta,Ruben Pio,Mercedes Garayoa,Enrique Zudaire,Miguel Julián,Ted H. Elsasser,Luis M. Montuenga,Alfredo Martínez +7 more
TL;DR: AM's traditional participation in normal physiology can be extended to a primary player in human carcinogenesis and may have clinical relevance as a biological target for the intervention of tumor progression.
Journal ArticleDOI
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects
Daniel Ajona,Carolina Zandueta,Leticia Corrales,Haritz Moreno,Maria J. Pajares,Sergio Ortiz-Espinosa,Elena Martínez-Terroba,Naiara Perurena,Fernando J. de Miguel,Eloisa Jantus-Lewintre,Carlos Camps,Silvestre Vicent,Jackeline Agorreta,Luis M. Montuenga,Ruben Pio,Fernando Lecanda +15 more
TL;DR: The role played by the C5a/C5aR1 axis in lung cancer dissemination is unveiled and its potential use as a novel therapeutic target is supported.